Aveanna Healthcare (NASDAQ:AVAH) Major Shareholder Sells $25,875,000.00 in Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) major shareholder J.H. Whitney Equity Partners V sold 2,250,000 shares of Aveanna Healthcare stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $11.50, for a total value of $25,875,000.00. Following the completion of the sale, the insider owned 12,315,892 shares of the company’s stock, valued at $141,632,758. The trade was a 15.45% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Major shareholders that own more than 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

J.H. Whitney Equity Partners V also recently made the following trade(s):

• On Thursday, August 20th, J.H. Whitney Equity Partners V sold 12,496,077 shares of Aveanna Healthcare stock. The shares were sold at an average price of $11.50, for a total transaction of $143,704,885.50.
• On Tuesday, June 30th, J.H. Whitney Equity Partners V sold 2,419,035 shares of Aveanna Healthcare stock. The shares were sold at an average price of $8.01, for a total transaction of $19,376,470.35.
• On Wednesday, June 24th, J.H. Whitney Equity Partners V sold 919,389 shares of Aveanna Healthcare stock. The stock was sold at an average price of $8.00, for a total transaction of $7,355,112.00.
• On Wednesday, June 3rd, J.H. Whitney Equity Partners V sold 5,842,240 shares of Aveanna Healthcare stock. The shares were sold at an average price of $6.24, for a total transaction of $36,455,577.60.

Aveanna Healthcare Stock Performance

Aveanna Healthcare stock traded up $0.54 during midday trading on Monday, reaching $13.70. 5,371,630 shares of the company traded hands, compared to its average volume of 1,804,159. Aveanna Healthcare Holdings Inc. has a 12 month low of $5.93 and a 12 month high of $13.98. The company has a debt-to-equity ratio of 4.47, a current ratio of 1.16 and a quick ratio of 1.16. The business has a 50 day moving average of $9.58 and a two-hundred day moving average of $7.92. The firm has a market capitalization of $2.99 billion, a price-to-earnings ratio of 11.14, a price-to-earnings-growth ratio of 0.92 and a beta of 1.90.

Aveanna Healthcare (NASDAQ:AVAH) last posted its earnings results on Thursday, August 13th. The company reported $0.22 EPS for the quarter, topping analysts’ consensus estimates of $0.17 by $0.05. The business had revenue of $670.48 million during the quarter, compared to the consensus estimate of $638.61 million. Aveanna Healthcare had a net margin of 10.56% and a return on equity of 80.70%. As a group, research analysts predict that Aveanna Healthcare Holdings Inc. will post 0.68 earnings per share for the current year.

Wall Street Analyst Weigh In

AVAH has been the topic of a number of recent research reports. Stephens raised Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and increased their target price for the company from $10.00 to $11.00 in a report on Friday, May 15th. Wall Street Zen downgraded Aveanna Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 15th. Truist Financial increased their price objective on shares of Aveanna Healthcare from $11.00 to $15.00 and gave the stock a “hold” rating in a research note on Monday. Royal Bank Of Canada raised their price objective on shares of Aveanna Healthcare from $10.00 to $16.00 and gave the stock an “outperform” rating in a report on Monday. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of Aveanna Healthcare in a research report on Thursday, July 2nd. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $12.89.

More Aveanna Healthcare News

Here are the key news stories impacting Aveanna Healthcare this week:

• Positive Sentiment: Royal Bank of Canada raised its price target for Aveanna Healthcare from $10 to $16 and upgraded the stock to “outperform.” The new target implies additional upside from recent trading levels, providing a bullish signal for AVAH. Benzinga analyst price-target report
• Neutral Sentiment: Truist Financial increased its price target from $11 to $15 but maintained a “hold” rating. The higher valuation suggests improved expectations, while the unchanged rating indicates the firm does not see a compelling reason to become more bullish after the stock’s recent advance. Benzinga analyst price-target report
• Negative Sentiment: Several insiders sold a combined 320,000 shares at an average price of $11.50, generating approximately $3.68 million. CEO Jeff Shaner sold 90,000 shares, director Rodney D. Windley sold 180,000, and insider Edwin C. Reisz sold 50,000. Each retained a substantial stake, but the coordinated sales—particularly Windley’s roughly 8% position reduction—could raise concerns about insider confidence or add near-term selling pressure. CEO insider sale filing Director insider sale filing Insider sale filing

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the stock. Caitong International Asset Management Co. Ltd increased its holdings in Aveanna Healthcare by 252.4% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock worth $27,000 after acquiring an additional 2,400 shares in the last quarter. Quantbot Technologies LP bought a new position in shares of Aveanna Healthcare in the second quarter worth approximately $43,000. Summit Securities Group LLC purchased a new stake in shares of Aveanna Healthcare in the first quarter worth $53,000. Oxford Asset Management LLP bought a new stake in shares of Aveanna Healthcare during the 2nd quarter valued at $64,000. Finally, C M Bidwell & Associates Ltd. purchased a new position in shares of Aveanna Healthcare during the 2nd quarter valued at $69,000. 87.96% of the stock is owned by hedge funds and other institutional investors.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.